Future Directions for Clinical Cancer Studies
نویسندگان
چکیده
منابع مشابه
Future directions in clinical research for lung cancer.
Even since the Surgeon General's 1964 report, the mortality rate from lung cancer has continued to rise. Although there is evidence that this continued increase in mortality will slow or level in the next decade, lung cancer mortality is a major health problem destined to remain with us for at least the next generation. There have been no established advances in the early detection or preventio...
متن کاملCurrent and future directions of clinical trials for ovarian cancer.
BACKGROUND The management of ovarian cancer includes a combination of surgery and chemotherapy. The majority of clinical trials have historically addressed questions pertaining to the selection, dosing, and schedule of chemotherapy agents. METHODS In this report, a comprehensive review of the major clinical trials in ovarian cancer is performed. The increasing data and clinical experience in ...
متن کاملGenome-wide association studies in cancer--current and future directions.
Genome-wide association studies (GWAS) have emerged as an important tool for discovering regions of the genome that harbor genetic variants that confer risk for different types of cancers. The success of GWAS in the last 3 years is due to the convergence of new technologies that can genotype hundreds of thousands of single-nucleotide polymorphism markers together with comprehensive annotation o...
متن کاملNSABP breast cancer clinical trials: recent results and future directions.
Over the past 40 years, the National Surgical Adjuvant Breast and Bowel Project (NSABP) has conducted several large, randomized clinical trials evaluating various aspects of surgical and adjuvant therapy in patients with operable breast cancer. Results from these trials have contributed significantly in reducing the extent of surgical procedures and in improving the outcome of patients with ear...
متن کاملFuture Directions for Immunotherapy in Ovarian Cancer
Immunotherapies involving cellular and checkpoint inhibitor approaches are under investigation in ovarian cancer and preliminary results suggest evidence of clinical benefit. Assumptions in the past of low immunogenicity of ovarian cancer appear to be changing as our new awareness of immune function activity with ovarian cancer, tumor microenvironment and molecular signaling is becoming evident...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: TRENDS IN THE SCIENCES
سال: 2003
ISSN: 1884-7080,1342-3363
DOI: 10.5363/tits.8.4_60